Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023

SELL
$37.58 - $52.57 $72,980 - $102,090
-1,942 Reduced 94.82%
106 $4,000
Q4 2022

Feb 08, 2023

SELL
$49.7 - $57.71 $68,486 - $79,524
-1,378 Reduced 40.22%
2,048 $104,000
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $107 - $133
2 Added 0.06%
3,426 $185,000
Q2 2022

Aug 12, 2022

BUY
$63.83 - $80.0 $63 - $80
1 Added 0.03%
3,424 $220,000
Q1 2022

May 12, 2022

SELL
$76.85 - $89.45 $61,787 - $71,917
-804 Reduced 19.02%
3,423 $266,000
Q4 2021

Feb 10, 2022

BUY
$74.57 - $87.19 $45,263 - $52,924
607 Added 16.77%
4,227 $363,000
Q3 2021

Nov 04, 2021

BUY
$73.77 - $83.61 $33,712 - $38,209
457 Added 14.45%
3,620 $291,000
Q2 2021

Nov 15, 2021

SELL
$80.5 - $88.01 $12,638 - $13,817
-157 Reduced 4.73%
3,163 $255,000
Q2 2021

Aug 05, 2021

BUY
$80.5 - $88.01 $20,849 - $22,794
259 Added 8.46%
3,320 $267,000
Q1 2021

May 17, 2021

BUY
$76.38 - $86.03 $173,840 - $195,804
2,276 Added 289.94%
3,061 $258,000
Q4 2020

Feb 16, 2021

BUY
$75.39 - $82.36 $75 - $82
1 Added 0.13%
785 $63,000
Q2 2020

Aug 07, 2020

BUY
$78.66 - $94.14 $78 - $94
1 Added 0.13%
784 $68,000
Q2 2019

Aug 13, 2019

BUY
$73.44 - $82.41 $17,992 - $20,190
245 Added 45.54%
783 $64,000
Q1 2019

May 13, 2019

BUY
$64.48 - $81.31 $3,933 - $4,959
61 Added 12.79%
538 $43,000
Q4 2018

Feb 13, 2019

SELL
$61.45 - $77.8 $3,318 - $4,201
-54 Reduced 10.17%
477 $31,000
Q3 2018

Nov 07, 2018

BUY
$70.71 - $77.75 $70 - $77
1 Added 0.19%
531 $0
Q2 2018

Aug 03, 2018

BUY
$63.43 - $75.41 $63 - $75
1 Added 0.19%
530 $0
Q4 2017

Feb 14, 2018

BUY
$61.45 - $66.05 $11,736 - $12,615
191 Added 56.51%
529 $34,000
Q4 2017

Feb 12, 2018

SELL
$61.45 - $66.05 $25,870 - $27,807
-421 Reduced 55.47%
338 $38,000
Q3 2017

Nov 06, 2017

BUY
$59.5 - $64.61 $45,160 - $49,038
759
759 $48,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.